Skip to main content
Clinical Trials/CTRI/2024/07/071016
CTRI/2024/07/071016Not yet recruitingPhase 2

AN OPEN LABEL RANDOMIZED STANDARD CONTROLLED CLINICAL TRIAL ON THE EFFECT OF SHALMALI MOOLA (Shalmalia Malabarica. L) TABLET IN OLIGOSPERMIA (KSHEENA SHUKRA) - NI

G.J. Patel Institute Of Ayurvedic Studies and Research0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Diagnosed cases of oligospermia
  • Sperm count less than 15 million/ml.

Exclusion Criteria

  • Patients with azoospermia & aspermia, Teratospermia more than14%
  • Patient with known sexually transmitted disease.
  • Sperm count greater than 15 million/ml.
  • Systemic diseases like known case of diabetes mellitus will be excluded from the study.
  • Semen samples showing high viscosity and low liquefaction time.

Investigators

Sponsor
G.J. Patel Institute Of Ayurvedic Studies and Research

Similar Trials